Skip to main content
Home
Zeitschriften
Zeitungen
Podcast
Gesundheitspolitik
Praxis
Allerlei
Jobs
Fachgebiete
Allgemeinmedizin Anästhesiologie & Intensivmedizin Apotheke Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kinder & Jugendheilkunde Neurologie & Psychiatrie Orthopädie & Unfallchirurgie Pflege Urologie Zahnmedizin
Subfächer Innere Medizin
Diabetologie Gastroenterologie Infektiologie Kardiologie Onkologie und Hämatologie Pneumologie Rheumatologie
Fortbildungen
Überblick Fortbildungen DFP-Literaturstudium-Artikel DFP-Webcast Fortbildungen DFP-Podcasts
Erweiterte Suche
Anmelden
nach oben
Wiener klinische Wochenschrift
Erschienen in:

04.02.2019 | original article

Diagnostic delay in patients with inflammatory bowel disease in Austria

verfasst von: Gottfried Novacek, M.D, Hans Peter Gröchenig, M.D., Thomas Haas, M.D., Heimo Wenzl, M.D., Pius Steiner, M.D., Robert Koch, M.D., Thomas Feichtenschlager, M.D., Gerald Eckhardt, M.D., Andreas Mayer, M.D., Andreas Kirchgatterer, M.D., Othmar Ludwiczek, M.D., Reingard Platzer, M.D., Pavol Papay, M.D., Johanna Gartner, M.D., Harry Fuchssteiner, M.D., Wolfgang Miehsler, M.D., Paul-Gerhard Peters, M.D., Gerhard Reicht, M.D., Harald Vogelsang, M.D., Clemens Dejaco, M.D., Thomas Waldhör, PhD, Austrian IBD Study Group (ATISG)

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 5-6/2019

Einloggen, um Zugang zu erhalten

Summary Background Methods Results Conclusion

Delayed diagnosis seems to be common in inflammatory bowel diseases (IBD). The study was carried out to investigate the diagnostic delay and associated risk factors in Austrian IBD patients.
In a multicenter cross-sectional study adult patients with IBD attending 18 Austrian outpatient clinics completed a multi-item questionnaire that recorded medical and socioeconomic characteristics. The study outcome was diagnostic delay defined as the period from symptom onset to diagnosis of IBD.
A total of 1286 patients (Crohn’s disease 830, ulcerative colitis 435, inflammatory bowel disease unclassified 21; females 651) with a median age of 40 years (interquartile range 31–52 years) and a median disease duration of 10 years (4–18 years) were analyzed. The median diagnostic delay was 6 months (2–23 months) in Crohn’s disease and 3 months (1–10 months) in ulcerative colitis (p < 0.001). In the multivariable regression analysis Crohn’s disease, greater age at diagnosis and a high educational level (compared to middle degree level) were independently associated with longer diagnostic delay.
The diagnostic delay was longer in Crohn’s disease than in ulcerative colitis patients and was associated with greater age at diagnosis and a higher educational level.
Vorheriger Artikel The European COPD audit
Nächster Artikel Outcome of no oral antibiotic prophylaxis and bowel preparation in Crohn’s diseases surgery
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Danese S, Fiorino G, Mary JY, Lakatos PL, D’Haens G, Moja L, et al. Development of red flags index for early referral of adults with symptoms and signs suggestive of Crohn’s disease: An IOIBD initiative. J Crohns Colitis. 2015;9:601–6.CrossRef
2.
Burgmann T, Clara I, Graff L, Walker J, Lix L, Rawsthorne P, et al. The Manitoba Inflammatory Bowel Disease Cohort Study: prolonged symptoms before diagnosis-how much is irritable bowel syndrome? Clin Gastroenterol Hepatol. 2006;4:614–20.CrossRef
3.
Loftus EV, Silverstein MD, Sandborn WJ, Tremaine WJ, Harmsen WS, Zinsmeister AR. Crohn’s disease in Olmsted County, Minnesota, 1940–1993: incidence, prevalence, and survival. Gastroenterology. 1998;114:1161–8.CrossRef
4.
Pimentel M, Chang M, Chow EJ, Tabibzadeh S, Kirit-Kiriak V, Targan SR, et al. Identification of a prodromal period in Crohn’s disease but not ulcerative colitis. Am J Gastroenterol. 2000;95:3458–62.CrossRef
5.
Romberg-Camps MJL, Hesselink-van de Kruijs MAM, Schouten LJ, Dagnelie PC, Limonard CB, Kester ADM, et al. Inflammatory bowel disease in South Limburg (the Netherlands) 1991–2002: incidence, diagnostic delay, and seasonal variations in onset of symptoms. J Crohns Colitis. 2009;3:115–24.CrossRef
6.
Vavricka SR, Spigaglia SM, Rogler G, Pittet V, Michetti P, Felley C, et al. Systematic evaluation of risk factors for diagnostic delay in inflammatory bowel disease. Inflamm Bowel Dis. 2012;18:496–505.CrossRef
7.
Schoepfer AM, Dehlavi MA, Fournier N, Safroneeva E, Straumann A, Pittet V, et al. Diagnostic delay in Crohn’s disease is associated with a complicated disease course and increased operation rate. Am J Gastroenterol. 2013;108:1744–53.CrossRef
8.
Nahon S, Lahmek P, Lesgourgues B, Poupardin C, Chaussade S, Peyrin-Biroulet L, et al. Diagnostic delay in a French cohort of Crohn’s diease patients. J Crohns Colitis. 2014;8:964–9.CrossRef
9.
Burisch J, Pedersen N, Cukovic-Cavka S, Brinar M, Kaimakliotis I, Duricova D, et al. East-West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort. Gut. 2014;63:588–97.CrossRef
10.
Lönnfors S, Vermeire S, Greco M, Hommes D, Bell C, Avedano L. IBD and health-related quality of life—discovering the true impact. J Crohns Colitis. 2014;8:1281–6.CrossRef
11.
Maconi G, Orlandi L, Asthana AK, Sciurti R, Furfaro F, Bezzio, et al. The impact of symptoms, irritable bowel syndrome pattern and diagnostic investigations on the diagnostic delay of Crohn’s disease: a prospective study. Dig Liver Dis. 2015;47:646–51.CrossRef
12.
Li Y, Ren J, Wang G, Gu G, Wu X, Ren H, et al. Diagnostic delay in Crohn’s disease is associated with increased rate of abdominal surgery: a retrospective study in Chinese patients. Dig Liver Dis. 2015;47:544–8.CrossRef
13.
Pellino G, Sciaudone G, Selvaggi F, Riegler G. Delayed diagnosis is influenced by the clinical pattern of Crohn’s disease and affects treatment outcomes and quality of life in the long term: a cross-sectional study of 361 patients in southern Italy. Eur J Gastroenterol Hepatol. 2015;27:175–81.CrossRef
14.
Moon CM, Jung SA, Kim SE, Song HJ, Ye BD, Cheon JH, et al. Clinical factors and disease course related to diagnostic delay in Korean Crohn’s disease patients: results from the CONNECT study. PLoS ONE. 2015;10(12):e144390.CrossRef
15.
Zaharie R, Tantau A, Zaharie F, Tantau M, Gheorghe L, Cheorghe C, et al. Diagnostic delay in Romanian patients with inflammatory bowel disease: risk factors and impact on the disease course and need for surgery. J Crohns Colitis. 2016;10:306–14.CrossRef
16.
Nahon S, Lahmek P, Paupard T, Lesgourgues B, Chaussade S, Peyrin-Biroulet L, et al. Diagnostic delay is associated with a greater risk of early surgery in a French cohort of Crohn’s disease patients. Dig Dis Sci. 2016;61:3278–84.CrossRef
17.
Cantoro L, Di Sabatino A, Papi C, Margagnoni G, Ardizzone S, Giuffrida P, et al. The time course of diagnostic delay in inflammatory bowel disease over the last sixty years: an Italian multicenter study. J Crohns Colitis. 2017;11:975–80.CrossRef
18.
Nguyen VQ, Jiang D, Hoffman SN, Guntaka S, Mays JL, Wang A, et al. Impact of diagnostic delay and associated factors on clinical outcomes in a U.S: inflammatory bowel disease cohort. Inflamm Bowel Dis. 2017;23:1825–31.CrossRef
19.
Lee DW, Koo JS, Choe JW, Suh SJ, Kim SY, Hyun JJ, et al. Diagnostic delay in inflammatory bowel disease increases the risk of intestinal surgery. World J Gastroenterol. 2017;23:6474–81.CrossRef
20.
Gomollón F, Dignass A, Annese V, Tilg H, Van Assche G, Lindsay JO, et al. 3rd European evidence-based consensus on the diagnosis and management of Crohn’s disease 2016: Part 1: Diagnosis and medical management. J Crohns Colitis. 2017;11:3–25.CrossRef
21.
Gionchetti P, Dignass A, Danese S, Magro DFJ, Rogler G, Lakatos PL, et al. 3rd European evidence-based consensus on the diagnosis and management of Crohn’s disease 2016: Part 2: Surgical management and special situations. J Crohns Colitis. 2017;11:135–49.CrossRef
22.
Peyrin-Biroulet L, Loftus EV Jr, Colombel JF, Sandborn WJ. Long-term complications, extraintestinal manifestations, and mortality in adult Crohn’s disease in population-based cohorts. Inflamm Bowel Dis. 2011;17:471–8.CrossRef
23.
Rieder F, Zimmermann EM, Remzi FH, Sandborn WJ. Crohn’s disease complicated by strictures: a systemic review. Gut. 2013;62:1072–84.CrossRef
24.
Magro F, Gionchetti P, Eliakim R, Ardizzone S, Armuzzi A, Barreiro-de Acosta M, et al. Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 1: Definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and ileo-anal pouch disorders. J Crohns Colitis. 2017;11:649–70.CrossRef
25.
Harbord M, Eliakim R, Bettenworth D, Karmiris K, Katsanos K, Kopylov U, et al. Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 2: current management. J Crohns Colitis. 2017;11:769–84.CrossRef
26.
Danese S, Fiocchi C. Ulcerative colitis. N Engl J Med. 2011;365:1713–25.CrossRef
27.
D’Haens G, Baert F, van Assche G, Caenepeel P, Vergauwe P, Tuynman H, et al. Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn’s disease: an open randomised trial. Lancet. 2008;371(9613):660–7.CrossRef
28.
Schreiber S, Colombel JF, Bloomfield R, Nikolaus S, Schölmerich J, Panés J, et al. Increased response and remission rates in short-duration Crohn’s disease with subcutaneous certolizumab pegol: an analysis of PRECISE 2 randomized maintenance trial data. Am J Gastroenterol. 2010;105:1574–82.CrossRef
29.
Khanna R, Bressler B, Levesque BG, Zou G, Stitt LW, Greenberg GR, et al. Early combined immunosuppression for the management of Crohn’s disease (REACT): a cluster randomized controlled trial. Lancet. 2015;386(10006):1825–34.CrossRef
30.
Allen PB, Peyrin-Biroulet L. Moving towards disease modification in inflammatory bowel disease therapy. Curr Opin Gastroenterol. 2013;29:397–404.CrossRef
31.
Peyrin-Biroulet L, Billioud V, D’Haens G, Panaccione R, Feagan B, Panés J, et al. Development of the Paris definition of early Crohn’s disease for disease-modification trials results of an international expert opinion process. Am J Gastroenterol. 2012;107:1770–6.CrossRef
32.
Peyrin-Biroulet L, Sandborn W, Sands BE, Reinisch W, Bemelman W, Bryant RV, et al. Selecting therapeutic targets in inflammatory bowel disease (STRIDE): determining therapeutic goals for treat-to-target. Am J Gastroenterol. 2015;110:1324–38.CrossRef
33.
Molodecky NA, Soon IS, Rabi DM, Ghail WA, Ferris M, Chernoff G, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142:46–54.CrossRef
34.
Van den Heuvel TRA, Jeuring SFG, Zeegers MP, van Dongen DHE, Wolters A, Masclee AAM, et al. A 20 year temporal change analysis in incidence, presenting phenotype and mortality in the Dutch IBDSL cohort—can diagnostic factors explain the increase in IBD incidence? J Crohns Colitis. 2017;11:1169–79.CrossRef
35.
Ghione S, Sarter H, Fumery M, Armengol-Debeir L, Savoye G, Ley D, et al. Dramatic increase in incidence of ulcerative colitis and Crohn’s disease (1988–2011): a population-based study of French adolescents. Am J Gastroenterol. 2018;113:265–72.CrossRef
36.
Bennette C, Vickers A. Against quantiles: categorization of continuous variables in epidemiologic research, and its discontents. Bmc Med Res Methodol. 2012;12:21.CrossRef
37.
Metadaten
Titel
Diagnostic delay in patients with inflammatory bowel disease in Austria
verfasst von
Gottfried Novacek, M.D
Hans Peter Gröchenig, M.D.
Thomas Haas, M.D.
Heimo Wenzl, M.D.
Pius Steiner, M.D.
Robert Koch, M.D.
Thomas Feichtenschlager, M.D.
Gerald Eckhardt, M.D.
Andreas Mayer, M.D.
Andreas Kirchgatterer, M.D.
Othmar Ludwiczek, M.D.
Reingard Platzer, M.D.
Pavol Papay, M.D.
Johanna Gartner, M.D.
Harry Fuchssteiner, M.D.
Wolfgang Miehsler, M.D.
Paul-Gerhard Peters, M.D.
Gerhard Reicht, M.D.
Harald Vogelsang, M.D.
Clemens Dejaco, M.D.
Thomas Waldhör, PhD
Austrian IBD Study Group (ATISG)
Publikationsdatum
04.02.2019
Verlag
Springer Vienna
Erschienen in
Wiener klinische Wochenschrift / Ausgabe 5-6/2019
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI
https://doi.org/10.1007/s00508-019-1451-3

Weitere Artikel der Ausgabe 5-6/2019

Veranstaltungstipps:

  • mitteilungen der gesellschaft der ärzte in wien

MUW researcher of the month

  • MUW researcher of the month

Correction to: Non-vitamin K antagonist oral anticoagulants in patients with an increased risk of bleeding

  • Correction

Assessment of children with pectus excavatum without surgical correction

  • original article

Oxygen titration in hypercapnic COPD exacerbation

  • letter to the editors

Outcome of no oral antibiotic prophylaxis and bowel preparation in Crohn’s diseases surgery

  • Open Access
  • original article